Houston
,
US
6 - 9 November 2025
American Society of Nephrology (ASN Kidney Week 2025)
Presentation schedule and materials
Thursday, 06 November 2025
10:00
- 12:00
CT
TH-PO0368
POSTER
Kidney, cardiovascular, and death outcomes with semaglutide treatment among two race and two ethnic groups: post hoc analysis from the FLOW trial
Carlos Campos, MD1; Richard Pratley, MD2; Katherine Tuttle, MD3; Sherif Mehanna, MD, MBS4; Caroline Swift, PhD, MPH4; Søren Rasmussen, PhD5; Peter Rossing, DMSc, MD6; Vlado Perkovic, PhD7; Kenneth Mahaffey, MD8; Christian Mende, MD9
MATERIALS AVAILABLE
10:00
- 12:00
CT
TH-PO0363
POSTER
Effect of semaglutide on HbA1c and body weight change by CKD stage: a post hoc analysis from the FLOW trial
Allon N. Friedman, MD1; Richard Pratley, MD2; Katherine Tuttle, MD3; Sherif Mehanna, MD, MBS4; Caroline Swift, PhD, MPH4; Søren Rasmussen, PhD5; Peter Rossing, DMSc, MD6; Vlado Perkovic, PhD7; Kenneth Mahaffey, MD8; Jan Basile, MD9
MATERIALS AVAILABLE
10:00
- 12:00
CT
TH-PO1213
POSTER
PHYOX8: Nedosiran in pediatric patients with primary hyperoxaluria
David J. Sas1,2,3, Sevcan A. Bakkaloglu4, Vladimir Belostotsky5, Gema Ariceta6, Gesa Schalk7, Loai A. Eid8, Jing Yu9, Jyoti Arora9
MATERIALS AVAILABLE
10:00
- 12:00
CT
TH-PO1194
POSTER
Going with the FLOW: Semaglutide and the Risk of Kidney Complications in Early Diabetic Kidney Disease – A Large Registry Study
Genya Aharon-Hananel1,2; Johannes F. Mann3; Alona Aharonovich4; Efrat Leopold5; Gil Chernin2,6
MATERIALS AVAILABLE
Friday, 07 November 2025
10:00
- 12:00
CT
FR-PO0279
POSTER
Evaluating physician preferences for siRNA therapy primary hyperoxaluria type 1 patients
Jing Voon Chen1 , Ambarish Ambegaonkar2, Bhargavi Mahadik2, Nishi Yadav2, Sandra Salem1; presented by Lissette Gutierrez
MATERIALS AVAILABLE
16:42
- 16:54
CT
FR-OR089
ORAL PRESENTATION
Mechanistic Effects of Semaglutide on Kidney Disease in Type 2 Diabetes: The REMODEL Trial
Katherine R. Tuttle1,2; Petter Bjornstad3,4; Menno Pruijm5; Jeffrey B. Hodgin6; David Z.I. Cherney7; Nicolas Belmar8; Milenta Mariam Chacko9; Vivek Das8; Thomas Idorn8; Philip A. Schytz8; Matthias Kretzler10
MATERIALS AVAILABLE
17:10
- 17:20
CT
ORAL PRESENTATION
Discordance between eGFRcystatin C and eGFRcreatinine and cardiovascular risk in the FLOW trial
Inga Soveri1; Johannes F.E. Mann2; Richard Pratley3; Roland E. Schmieder4; David Cherney5; Richard MacIsaac6; Peter Rossing7; Kenneth W. Mahaffey8; L. Sreenivasamurthy9; Srikanth Bellary10,11, Vlado Perkovic12; Soo Kun Lim13; Janusz Gumprecht14; Nicolas Belmar15; Heidrun Bosch-Traberg15; Søren Rasmussen15; Katherine Tuttle16,17; David M. Charytan18
MATERIALS AVAILABLE
Saturday, 08 November 2025
10:00
- 12:00
CT
SA-PO1219
POSTER
Systemic Inflammation and Risk of Adverse Kidney Outcomes in a Veteran Affairs Population With Atherosclerotic Cardiovascular Disease and Chronic Kidney Disease
Kimberly Zitko1; Alexander T. Sandhu2,3; Adam Furst2,3; David J. Maron2; Shriram Nallamshetty2,3; Natasha Din3; Kat Khachatourian1; Jeffrey R. Skaar1; Ivy Tonnu-Mihara1
MATERIALS AVAILABLE
10:00
- 12:00
CT
SA-PO1155
POSTER
Effect of semaglutide on kidney outcomes: Pooled analysis of the SELECT, FLOW, and SOUL trials
Johannes F.E. Mann1; Sunil V. Badve2,3; Florian M.M. Baeres4; Nicolas Belmar4; Kirstine Brown-Frandsen4; John B. Buse5; Helen M. Colhoun6; John E. Deanfield7; Mads D. M. Engelmann4; G. Kees Hovingh4; Thomas Idorn4; A. Michael Lincoff8; Ildiko Lingvay9; Kenneth W. Mahaffey10; Darren K. McGuire11; Richard Pratley12; Søren Rasmussen4; Peter Rossing13; Naveed Sattar14; Katherine Tuttle15,16; Vlado Perkovic3
MATERIALS AVAILABLE
10:00
- 12:00
CT
SA-PO1157
POSTER
FLOW: Effects of semaglutide on kidney failure using the Kidney Failure Risk Equation
L. Sreenivasamurthy1; Mustafa Arici2; Willem A. Bax3; Robert Busch4; Ricardo Correa-Rotter5; José Luis Górriz6; Janusz Gumprecht7; Thomas Idorn8; Kenneth W. Mahaffey9; Johannes F.E. Mann10; Manuel M. Mayrdorfer8; Rikke Baastrup Nordsborg8; Richard Pratley11; Giuseppe Pugliese12; Daniel Guldager Kring Rasmussen8; Peter Rossing13; Navdeep Tangri14; Katherine R. Tuttle15,16; Vlado Perkovic17
MATERIALS AVAILABLE
Keywords